Compared to glass vials the pouches are lighter and smaller, so they reduce the cost and footprint of the cold chain. This new technology for filling, transporting, and delivering vaccines makes the multi-dose pouches particularly suitable for use in low-resource settings. IPD will fill the finished vaccine – known as drug product – into sterile plastic pouches similar to IV drip bags, which can hold and transport 200 doses of vaccine per pouch, as an alternative to filling the finished vaccine into conventional glass vials. IPD has selected this novel technology to accelerate the scale up of their vaccine production capabilities and facilitate rapid delivery of vaccines for Africa. Innovative technology to speed up vaccine production and delivery CEPI will also advise on the implementation of an innovative vaccine filling and delivery solution, licensed from MedInstill/INTACT Solutions and developed with CEPI’s funding and support. In the future, IPD plans to expand to produce vaccines against other pathogens that are relevant to the region – potentially also new vaccines funded by CEPI.ĬEPI will provide strategic and technical support to IPD’s MADIBA project to advance the development and delivery of vaccines manufacturing in Africa. IPD has previously signed an MOU with BioNTech to pursue mRNA vaccine manufacturing and is actively exploring partnerships with other vaccine companies to produce licensed COVID-19 vaccines in its new manufacturing facility. With the manufacturing facility in advanced construction, IPD is on track to start vaccine production in the third quarter of 2022. In its initial phase, IPD’s new modular facility will manufacture up to 300 million doses of COVID-19 vaccine annually for use in Africa. DAKAR, Senegal and OSLO, Norway 18 January 2022: The Coalition for Epidemic Preparedness Innovations (CEPI) and the Institut Pasteur de Dakar (IPD) have signed a Memorandum of Understanding (MoU) to formalize the partnership between the two organizations to advance IPD’s MADIBA project, a regional manufacturing hub for COVID-19 and other vaccines in Dakar, Sénégal.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |